Catalyst Funds Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,000	Closed	-$378K	–	662
2025 Q1	$378K	Sell	21,000 -2,700	-11%	-$48.6K	0.1%	228
2024 Q4	$399K	Buy	23,700 +21,000	+778%	+$353K	0.1%	180
2024 Q3	$43.7K	Buy	+2,700	New	+$43.7K	0.01%	847